SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bone Biologics Corp. – ‘S-1’ on 1/30/24 – ‘EX-101.SCH’

On:  Tuesday, 1/30/24, at 5:09pm ET   ·   Accession #:  1493152-24-4349   ·   File #:  333-276771

Previous ‘S-1’:  ‘S-1/A’ on 6/13/23   ·   Next:  ‘S-1/A’ on 2/23/24   ·   Latest:  ‘S-1/A’ on 2/26/24   ·   24 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/30/24  Bone Biologics Corp.              S-1                   64:9.1M                                   M2 Compliance LLC/FA

Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   2.72M 
 2: EX-4.2      Instrument Defining the Rights of Security Holders  HTML    227K 
 3: EX-4.5      Instrument Defining the Rights of Security Holders  HTML    135K 
 4: EX-4.6      Instrument Defining the Rights of Security Holders  HTML    133K 
 5: EX-4.7      Instrument Defining the Rights of Security Holders  HTML    147K 
 6: EX-10.2     Material Contract                                   HTML     87K 
 7: EX-23.1     Consent of Expert or Counsel                        HTML     18K 
 8: EX-FILING FEES  Calculation of Filing Fee Tables                HTML     27K 
14: R1          Cover                                               HTML     53K 
15: R2          Condensed Consolidated Balance Sheets               HTML     82K 
16: R3          Condensed Consolidated Balance Sheets               HTML     39K 
                (Parenthetical)                                                  
17: R4          Condensed Consolidated Statements of Operations     HTML     93K 
18: R5          Consolidated Statement of Stockholders' Equity      HTML     94K 
19: R6          Consolidated Statement of Stockholders' Equity      HTML     22K 
                (Parenthetical)                                                  
20: R7          Condensed Consolidated Statements of Cash Flows     HTML     87K 
21: R8          The Company                                         HTML     51K 
22: R9          Summary of Significant Accounting Policies          HTML    124K 
23: R10         Warrant Liability                                   HTML     52K 
24: R11         Income Taxes                                        HTML     75K 
25: R12         Stockholders? Equity                                HTML     58K 
26: R13         Common Stock Warrants                               HTML     91K 
27: R14         Stock-based Compensation                            HTML    197K 
28: R15         Commitments and Contingencies                       HTML     99K 
29: R16         Subsequent Events                                   HTML     47K 
30: R17         Summary of Significant Accounting Policies          HTML    152K 
                (Policies)                                                       
31: R18         Summary of Significant Accounting Policies          HTML     77K 
                (Tables)                                                         
32: R19         Warrant Liability (Tables)                          HTML     46K 
33: R20         Income Taxes (Tables)                               HTML     71K 
34: R21         Common Stock Warrants (Tables)                      HTML     88K 
35: R22         Stock-based Compensation (Tables)                   HTML    175K 
36: R23         The Company (Details Narrative)                     HTML     64K 
37: R24         Schedule of Fair Value Liabilities Measured On      HTML     32K 
                Recurring Basis (Details)                                        
38: R25         Schedule of Warrant Liability Measured Fair Value   HTML     27K 
                On A Recurring Basis Using Unobservable (Details)                
39: R26         Schedule of Antidilutive Securities Excluded from   HTML     27K 
                Computation of Earnings Per Share (Details)                      
40: R27         Summary of Significant Accounting Policies          HTML     28K 
                (Details Narrative)                                              
41: R28         Schedule of Warrant Liability Black-Scholes Model   HTML     40K 
                (Details)                                                        
42: R29         Schedule of Provision for Income Taxes (Details)    HTML     39K 
43: R30         Schedule of Deferred Tax Assets and Liabilities     HTML     34K 
                (Details)                                                        
44: R31         Schedule of Income Tax Effective Tax Rate           HTML     36K 
                (Details)                                                        
45: R32         Income Taxes (Details Narrative)                    HTML     26K 
46: R33         Stockholders? Equity (Details Narrative)            HTML    130K 
47: R34         Schedule of Warrant Activity (Details)              HTML     48K 
48: R35         Schedule of Outstanding Vested and Unexercised      HTML     51K 
                Common Stock Warrants (Details)                                  
49: R36         Common Stock Warrants (Details Narrative)           HTML     25K 
50: R37         Schedule of Stock Option Activity (Details)         HTML     60K 
51: R38         Schedule of Outstanding Stock Options (Details)     HTML     84K 
52: R39         Schedule of Assumptions Using Black-Scholes Option  HTML     43K 
                Pricing Model (Details)                                          
53: R40         Stock-based Compensation (Details Narrative)        HTML     54K 
54: R41         Commitments and Contingencies (Details Narrative)   HTML    103K 
55: R42         Schedule of Fair Value Liabilities Measured on      HTML     32K 
                Recurring Basic (Details)                                        
56: R43         Schedule of Warrant Liability Measured Fair Value   HTML     25K 
                on a Recurring Basic Using Unobservable (Details)                
57: R44         Schedule of Anti Dilutive Securities Excluded from  HTML     27K 
                Computation of Earnings Per Share (Details)                      
58: R45         Schedule of Assumptions Using Black-Scholes Option  HTML     28K 
                Pricing Mode (Details)                                           
59: R46         Subsequent Events (Details Narrative)               HTML    113K 
61: XML         IDEA XML File -- Filing Summary                      XML    105K 
64: XML         XBRL Instance -- forms-1_htm                         XML   1.91M 
60: EXCEL       IDEA Workbook of Financial Report Info              XLSX    126K 
10: EX-101.CAL  XBRL Calculations -- bblg-20230930_cal               XML    101K 
11: EX-101.DEF  XBRL Definitions -- bblg-20230930_def                XML    493K 
12: EX-101.LAB  XBRL Labels -- bblg-20230930_lab                     XML    906K 
13: EX-101.PRE  XBRL Presentations -- bblg-20230930_pre              XML    692K 
 9: EX-101.SCH  XBRL Schema -- bblg-20230930                         XSD    139K 
62: JSON        XBRL Instance as JSON Data -- MetaLinks              335±   489K 
63: ZIP         XBRL Zipped Folder -- 0001493152-24-004349-xbrl      Zip    592K

‘EX-101.SCH’   —   XBRL Schema — bblg-20230930

This Exhibit is an XBRL File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
<!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaWG+bP9z5Z8WekhvWB9bcka7yApNVql/i1PRP72od0B -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:BBLG="http://bonebiologics.com/20230930" elementFormDefault="qualified" targetNamespace="http://bonebiologics.com/20230930">
<annotation>
<appinfo>
<link:roleType roleURI="http://bonebiologics.com/role/Cover" id="Cover">
<link:definition> 00000001 - Document - Cover </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/BalanceSheets" id="BalanceSheets">
<link:definition> 00000002 - Statement - Condensed Consolidated Balance Sheets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
<link:definition> 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/StatementsOfOperations" id="StatementsOfOperations">
<link:definition> 00000004 - Statement - Condensed Consolidated Statements of Operations </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/StatementOfStockholdersEquity" id="StatementOfStockholdersEquity">
<link:definition> 00000005 - Statement - Consolidated Statement of Stockholders' Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/StatementOfStockholdersEquityParenthetical" id="StatementOfStockholdersEquityParenthetical">
<link:definition> 00000006 - Statement - Consolidated Statement of Stockholders' Equity (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
<link:definition> 00000007 - Statement - Condensed Consolidated Statements of Cash Flows </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/Company" id="Company">
<link:definition> 00000008 - Disclosure - The Company </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition> 00000009 - Disclosure - Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/WarrantLiability" id="WarrantLiability">
<link:definition> 00000010 - Disclosure - Warrant Liability </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/IncomeTaxes" id="IncomeTaxes">
<link:definition> 00000011 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/StockholdersEquity" id="StockholdersEquity">
<link:definition> 00000012 - Disclosure - Stockholders’ Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/CommonStockWarrants" id="CommonStockWarrants">
<link:definition> 00000013 - Disclosure - Common Stock Warrants </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/Stock-basedCompensation" id="Stock-basedCompensation">
<link:definition> 00000014 - Disclosure - Stock-based Compensation </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition> 00000015 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition> 00000016 - Disclosure - Subsequent Events </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 00000017 - Disclosure - Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
<link:definition> 00000018 - Disclosure - Summary of Significant Accounting Policies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/WarrantLiabilityTables" id="WarrantLiabilityTables">
<link:definition> 00000019 - Disclosure - Warrant Liability (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
<link:definition> 00000020 - Disclosure - Income Taxes (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/CommonStockWarrantsTables" id="CommonStockWarrantsTables">
<link:definition> 00000021 - Disclosure - Common Stock Warrants (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/Stock-basedCompensationTables" id="Stock-basedCompensationTables">
<link:definition> 00000022 - Disclosure - Stock-based Compensation (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/CompanyDetailsNarrative" id="CompanyDetailsNarrative">
<link:definition> 00000023 - Disclosure - The Company (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetails" id="ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetails">
<link:definition> 00000024 - Disclosure - Schedule of Fair Value Liabilities Measured On Recurring Basis (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfWarrantLiabilityMeasuredFairValueOnRecurringBasisUsingUnobservableDetails" id="ScheduleOfWarrantLiabilityMeasuredFairValueOnRecurringBasisUsingUnobservableDetails">
<link:definition> 00000025 - Disclosure - Schedule of Warrant Liability Measured Fair Value On A Recurring Basis Using Unobservable (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" id="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails">
<link:definition> 00000026 - Disclosure - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
<link:definition> 00000027 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfWarrantLiabilityBlack-scholesModelDetails" id="ScheduleOfWarrantLiabilityBlack-scholesModelDetails">
<link:definition> 00000028 - Disclosure - Schedule of Warrant Liability Black-Scholes Model (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfProvisionForIncomeTaxesDetails" id="ScheduleOfProvisionForIncomeTaxesDetails">
<link:definition> 00000029 - Disclosure - Schedule of Provision for Income Taxes (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" id="ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
<link:definition> 00000030 - Disclosure - Schedule of Deferred Tax Assets and Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfIncomeTaxEffectiveTaxRateDetails" id="ScheduleOfIncomeTaxEffectiveTaxRateDetails">
<link:definition> 00000031 - Disclosure - Schedule of Income Tax Effective Tax Rate (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
<link:definition> 00000032 - Disclosure - Income Taxes (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
<link:definition> 00000033 - Disclosure - Stockholders’ Equity (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfWarrantActivityDetails" id="ScheduleOfWarrantActivityDetails">
<link:definition> 00000034 - Disclosure - Schedule of Warrant Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfOutstandingVestedAndUnexercisedCommonStockWarrantsDetails" id="ScheduleOfOutstandingVestedAndUnexercisedCommonStockWarrantsDetails">
<link:definition> 00000035 - Disclosure - Schedule of Outstanding Vested and Unexercised Common Stock Warrants (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/CommonStockWarrantsDetailsNarrative" id="CommonStockWarrantsDetailsNarrative">
<link:definition> 00000036 - Disclosure - Common Stock Warrants (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfStockOptionActivityDetails" id="ScheduleOfStockOptionActivityDetails">
<link:definition> 00000037 - Disclosure - Schedule of Stock Option Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfOutstandingStockOptionsDetails" id="ScheduleOfOutstandingStockOptionsDetails">
<link:definition> 00000038 - Disclosure - Schedule of Outstanding Stock Options (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfAssumptionsUsingBlack-scholesOptionPricingModelDetails" id="ScheduleOfAssumptionsUsingBlack-scholesOptionPricingModelDetails">
<link:definition> 00000039 - Disclosure - Schedule of Assumptions Using Black-Scholes Option Pricing Model (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/Stock-basedCompensationDetailsNarrative" id="Stock-basedCompensationDetailsNarrative">
<link:definition> 00000040 - Disclosure - Stock-based Compensation (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
<link:definition> 00000041 - Disclosure - Commitments and Contingencies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasicDetails" id="ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasicDetails">
<link:definition> 00000042 - Disclosure - Schedule of Fair Value Liabilities Measured on Recurring Basic (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfWarrantLiabilityMeasuredFairValueOnRecurringBasicUsingUnobservableDetails" id="ScheduleOfWarrantLiabilityMeasuredFairValueOnRecurringBasicUsingUnobservableDetails">
<link:definition> 00000043 - Disclosure - Schedule of Warrant Liability Measured Fair Value on a Recurring Basic Using Unobservable (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfAntiDilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetailsDisclosure" id="ScheduleOfAntiDilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetailsDisclosure">
<link:definition> 00000044 - Disclosure - Schedule of Anti Dilutive Securities Excluded from Computation of Earnings Per Share (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/ScheduleOfAssumptionsUsingBlack-scholesOptionPricingModeDetails" id="ScheduleOfAssumptionsUsingBlack-scholesOptionPricingModeDetails">
<link:definition> 00000045 - Disclosure - Schedule of Assumptions Using Black-Scholes Option Pricing Mode (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bonebiologics.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
<link:definition> 00000046 - Disclosure - Subsequent Events (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="bblg-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="bblg-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="bblg-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="bblg-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
<import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
<import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
<element id="BBLG_FDASpineInterbodyFusionMember" name="FDASpineInterbodyFusionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_MeasurementInputExpectedVolatilityMember" name="MeasurementInputExpectedVolatilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_MeasurementInputExpectedDividendYieldMember" name="MeasurementInputExpectedDividendYieldMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_SeriesAWarrantMember" name="SeriesAWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_SeriesBWarrantMember" name="SeriesBWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_SeriesCWarrantMember" name="SeriesCWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_WallachBethCapitalLLCMember" name="WallachBethCapitalLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_HankeyCapitalLLCMember" name="HankeyCapitalLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_UnderwritingAgreementMember" name="UnderwritingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_OctoberTwoThousandTwentyOneMember" name="OctoberTwoThousandTwentyOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_VestedAndUnexercisedCommonStockWarrantsMember" name="VestedAndUnexercisedCommonStockWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_OctoberTwoThousandTwentyTwoOneMember" name="OctoberTwoThousandTwentyTwoOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_OctoberTwoThousandTwentyTwoTwoMember" name="OctoberTwoThousandTwentyTwoTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_OctoberTwoThousandTwentyTwoThreeMember" name="OctoberTwoThousandTwentyTwoThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_OctoberTwoThousandTwentyTwoMember" name="OctoberTwoThousandTwentyTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_TwoThousandFifteenEquityIncentivePlanMember" name="TwoThousandFifteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_AugustTwoThousandFifteenMember" name="AugustTwoThousandFifteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_SeptemberTwoThousandFifteenMember" name="SeptemberTwoThousandFifteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_NovemberTwoThousandFifteenMember" name="NovemberTwoThousandFifteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_DecemberTwoThousandFifteenMember" name="DecemberTwoThousandFifteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_JanuaryTwoThousandSixteenMember" name="JanuaryTwoThousandSixteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_MayTwoThousandSixteenMember" name="MayTwoThousandSixteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_SeptemberTwoThousandSixteenMember" name="SeptemberTwoThousandSixteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_JanuaryTwoThousandSeventeenMember" name="JanuaryTwoThousandSeventeenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_JanuaryTwoThousandEighteenMember" name="JanuaryTwoThousandEighteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_JanuaryTwoThousandNineteenMember" name="JanuaryTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_JanuaryTwoThousandTwentyTwoMember" name="JanuaryTwoThousandTwentyTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_JanuaryTwoThousandTwentyTwoOneMember" name="JanuaryTwoThousandTwentyTwoOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_JanuaryTwoThousandTwentyTwoTwoMember" name="JanuaryTwoThousandTwentyTwoTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_AugustTwoThousandTwentyTwoMember" name="AugustTwoThousandTwentyTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_JanuaryTwoThousandTwentyThreeMember" name="JanuaryTwoThousandTwentyThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_SeptemberTwoThousandTwentyThreeMember" name="SeptemberTwoThousandTwentyThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_LicenseAgreementMember" name="LicenseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_FirstCommercialSaleMember" name="FirstCommercialSaleMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_AfterFirstCommercialSaleMember" name="AfterFirstCommercialSaleMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ThirdPartyMember" name="ThirdPartyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_UniversityOfCaliforniaLosAngelesTechnologyDevelopmentGroupMember" name="UniversityOfCaliforniaLosAngelesTechnologyDevelopmentGroupMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_FirstSubjectInFeasibilityStudyMember" name="FirstSubjectInFeasibilityStudyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_FirstSubjectInPivotalStudyMember" name="FirstSubjectInPivotalStudyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_PreMarketApprovalOfLicensedProductOrLicensedMethodMember" name="PreMarketApprovalOfLicensedProductOrLicensedMethodMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_FirstCommercialSaleOfLicensedProductOrLicensedMethodMember" name="FirstCommercialSaleOfLicensedProductOrLicensedMethodMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ScenarioOneMember" name="ScenarioOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ScenarioTwoMember" name="ScenarioTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ScenarioThreeMember" name="ScenarioThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_OneVendorMember" name="OneVendorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_AmendedLicenseAgreementMember" name="AmendedLicenseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_FrelickMember" name="FrelickMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_WalshMember" name="WalshMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_SettlementAgreementMember" name="SettlementAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_March122024Member" name="March122024Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_June122024Member" name="June122024Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_September122024Member" name="September122024Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_WarrantLiability" name="WarrantLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_FinanceCostRelatedToPublicOffering" name="FinanceCostRelatedToPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_GainOnForgivenessOfDeferredCompensation" name="GainOnForgivenessOfDeferredCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_CancellationOfCollateralSharesUponDebtConversion" name="CancellationOfCollateralSharesUponDebtConversion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_CancellationOfCollateralSharesUponDebtConversionShares" name="CancellationOfCollateralSharesUponDebtConversionShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_StockIssuedDuringPeriodValueWarrantLiability" name="StockIssuedDuringPeriodValueWarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_StockIssuedDuringPeriodValueExerciseOfWarrants" name="StockIssuedDuringPeriodValueExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_StockIssuedDuringPeriodSharesExerciseOfWarrants" name="StockIssuedDuringPeriodSharesExerciseOfWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ShareAdjustmentForStockSplitRounding" name="ShareAdjustmentForStockSplitRounding" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_InterestPayableRelatedParty" name="InterestPayableRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_IssuanceOfSharesUponCashlessExerciseOfWarrants" name="IssuanceOfSharesUponCashlessExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ExtinguishmentOfWarrantLiabilityUponExerciseOfWarrants" name="ExtinguishmentOfWarrantLiabilityUponExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_DisclosureWarrantLiabilityAbstract" name="DisclosureWarrantLiabilityAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_WarrantLiabilitiesDisclosuresTextBlock" name="WarrantLiabilitiesDisclosuresTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_DisclosureCommonStockWarrantsAbstract" name="DisclosureCommonStockWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_CommonStockWarrantsTextBlock" name="CommonStockWarrantsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_UnusualOrInfrequentItemsDisclosurePolicyTextBlock" name="UnusualOrInfrequentItemsDisclosurePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_InflationPolicyTextBlock" name="InflationPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_PrepaidExpensesPolicyTextBlock" name="PrepaidExpensesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ScheduleOfWarrantLiabilityBlackScholesModelTableTextBlock" name="ScheduleOfWarrantLiabilityBlackScholesModelTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ScheduleOfOutstandingVestedAndUnexercisedCommonStockWarrantsTableTextBlock" name="ScheduleOfOutstandingVestedAndUnexercisedCommonStockWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_EstimatedOperatingExpenditure" name="EstimatedOperatingExpenditure" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_AddtionalOtherCostAndExpenseOperating" name="AddtionalOtherCostAndExpenseOperating" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_WarrantLiabilities" name="WarrantLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_FairValueOfWarrantLiabilityRecognizedUponIssuanceOfWarrants" name="FairValueOfWarrantLiabilityRecognizedUponIssuanceOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_CashSIPCInsuredAmount" name="CashSIPCInsuredAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_FairValueOfWarrantLiability" name="FairValueOfWarrantLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_OfferingPricePercentage" name="OfferingPricePercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_OfferingPortionPercentage" name="OfferingPortionPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_DebtConversionConvertedInstrumentAmount" name="DebtConversionConvertedInstrumentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ProceedsFromUnderwritingDiscounts" name="ProceedsFromUnderwritingDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageRemainingContractualTermBeginning" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageRemainingContractualTermBeginning" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageRemainingContractualTermGranted" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageRemainingContractualTermGranted" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageRemainingContractualTermExercised" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageRemainingContractualTermExercised" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageRemainingContractualTermEnding" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageRemainingContractualTermEnding" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTermGranted" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTermGranted" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_PercentageOfStockIssuedAndOutstanding" name="PercentageOfStockIssuedAndOutstanding" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_MaintenanceFees" name="MaintenanceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_PercentageOfCommercialSaleOfLicensedProductEqualToNetSales" name="PercentageOfCommercialSaleOfLicensedProductEqualToNetSales" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_RoyaltyPercentageReduced" name="RoyaltyPercentageReduced" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_LicenseCommitmentFee" name="LicenseCommitmentFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_DiligenceFee" name="DiligenceFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_CumulativeNetSalesDescription" name="CumulativeNetSalesDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_PercentageOfAmountRaisedInPrivatePlacement" name="PercentageOfAmountRaisedInPrivatePlacement" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_AmountsRemainingForServicesValue" name="AmountsRemainingForServicesValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_LicensedSalesPercentage" name="LicensedSalesPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_MinimumBidPrice" name="MinimumBidPrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_IssuanceOfWarrantShares" name="IssuanceOfWarrantShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item"/>
<element id="BBLG_ShareAdjustmentForStockSplitRoundingShares" name="ShareAdjustmentForStockSplitRoundingShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
</schema>

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/26/24  Bone Biologics Corp.              S-1/A                  3:393K                                   M2 Compliance LLC/FA
 2/23/24  Bone Biologics Corp.              S-1/A                  7:1.3M                                   M2 Compliance LLC/FA
 2/21/24  Bone Biologics Corp.              10-K       12/31/23   63:6.3M                                   M2 Compliance LLC/FA
 2/05/24  SEC                               UPLOAD4/02/24    2:39K  Bone Biologics Corp.

20 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/17/24  Bone Biologics Corp.              S-3/A                  3:632K                                   M2 Compliance LLC/FA
 1/05/24  Bone Biologics Corp.              S-3                    5:490K                                   M2 Compliance LLC/FA
12/18/23  Bone Biologics Corp.              8-K:3,5,8,912/14/23   13:313K                                   M2 Compliance LLC/FA
11/20/23  Bone Biologics Corp.              8-K:1,3,8,911/16/23   16:947K                                   M2 Compliance LLC/FA
10/24/23  Bone Biologics Corp.              8-K:5      10/20/23   12:253K                                   M2 Compliance LLC/FA
 8/03/23  Bone Biologics Corp.              DEF 14A     8/03/23    1:1.6M                                   M2 Compliance LLC/FA
 6/06/23  Bone Biologics Corp.              8-K:5,9     6/05/23   12:3.1M                                   M2 Compliance LLC/FA
10/11/22  Bone Biologics Corp.              8-K:1,8,9  10/07/22   14:1.4M                                   M2 Compliance LLC/FA
 6/09/22  Bone Biologics Corp.              8-K:1,9     6/08/22   12:306K                                   M2 Compliance LLC/FA
 3/15/22  Bone Biologics Corp.              10-K       12/31/21   59:5M                                     M2 Compliance LLC/FA
 3/08/22  Bone Biologics Corp.              8-K:1,5,8,9 3/03/22   13:574K                                   M2 Compliance LLC/FA
12/22/21  Bone Biologics Corp.              8-K:1,9    12/17/21   12:10M                                    M2 Compliance LLC/FA
10/15/21  Bone Biologics Corp.              8-K:1,5,8,910/13/21   15:1.8M                                   M2 Compliance LLC/FA
10/07/21  Bone Biologics Corp.              S-1/A                 60:9.2M                                   M2 Compliance LLC/FA
 4/16/19  Bone Biologics Corp.              8-K:1,9     4/09/19    2:436K                                   M2 Compliance LLC/FA
 2/26/16  Bone Biologics Corp.              8-K:1,3,9   2/22/16    7:509K                                   M2 Compliance LLC/FA
 1/11/16  Bone Biologics Corp.              8-K:1,3,9   1/08/16    2:79K                                    M2 Compliance LLC/FA
 1/04/16  Bone Biologics Corp.              8-K:1,5,9  12/28/15    6:444K                                   M2 Compliance LLC/FA
 8/14/15  Bone Biologics Corp.              10-Q        6/30/15   64:6.9M                                   M2 Compliance LLC/FA
 9/25/14  Bone Biologics Corp.              8-K:1,2,3,5 9/19/14   79:9M                                     M2 Compliance LLC/FA
↑Top
Filing Submission 0001493152-24-004349   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Mon., May 13, 2:54:25.3pm ET